Skip to main content
. 2022 Sep 24;140(21):2228–2247. doi: 10.1182/blood.2022015853

Figure 1.

Figure 1.

How molecular profiling can inform clinical decision making in MDS. IPSS-M, Molecular International Prognostic Scoring System; MDS, myelodysplastic syndrome; MRD, minimal/measurable residual disease. Professional illustration by Patrick Lane, ScEYEnce Studios.